Mitochondrial Perturbance and Execution of Apoptosis in Platelet Mitochondria of Patients With Amyotrophic Lateral Sclerosis

REFERENCES

• Barber, S. C., Mead, R. J., & Shaw, P. J. (2006). Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochimica et Biophysica Acta, 1762(11–12), 1051–1067.
   PubMed Web of Science ®Google Scholar
• Beal, M. F. (1996). Mitochondria, free radicals, and neurodegeneration. Current Opinion Neurobiology, 6(5), 661–666.
   PubMed Web of Science ®Google Scholar
• Bos, I. W., Hoogland, G., Meine Jansen, C. F., Willigen, G., Spierenburg, H. A., Van Den Berg, L. H., (2006). Increased glutamine synthetase but normal EAAT2 expression in platelets of ALS patients. Neurochemistry International, 48(4), 306–311.
   PubMedGoogle Scholar
• Brooks, B. R. (1994). El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. Journal of Neurological Sciences, 124, 96–107.
   PubMed Web of Science ®Google Scholar
• Brustovetsky, N., Brustovetsky, T., Jemmerson, R., & Dubinsky, J. M. (2002). Calcium induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. Journal of Neurochemistry, 80(2), 207–218.
   PubMedGoogle Scholar
• Buckman, J. F., Hernández, H., Kress, G. J., Votyakova, T. V., Pal, S., & Reynolds, I. J. (2001). Mitotracker labeling in primary neuronal and astrocytic cultures: Influence of mitochondrial membrane potential and oxidants. Journal of Neuroscience Methods, 104(2), 165–176.
   PubMedGoogle Scholar
• Carole Ferraro-Peyret, Quemeneur, L., Flacher, M., Revillard, J. P., & Genestier, L. (2002). Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. Journal of Immunology, 169, 4805–4810.
   PubMedGoogle Scholar
• Castedo, M., Hirsch, T., Susin, S. A., Zamzami, N., Marchetti, P., Macho, A., (1996). Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. Journal of Immunology, 157(2), 512–521.
   PubMed Web of Science ®Google Scholar
• Chaudhuri, K. R., Crump, S., al-Sarraj, S., Anderson, V., Cavanagh, J., & Leigh, P. N. (1995). The validation of El Escorial criteria for the diagnosis of amyotrophic lateral sclerosis: A clinicopathological study. Journal of Neurological Sciences, 129, 11–12.
   PubMed Web of Science ®Google Scholar
• Cleveland, D. W., & Rothstein, J. D. (2001). From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience, 2(11), 806–819.
   PubMed Web of Science ®Google Scholar
• Cossarizza, A., Ceccarelli, D., & Masini, A. (1996). Functional heterogeneity of isolated mitochondrial population revealed by cytofluorimetric analysis at the single organelle level. Experimental Cell Research, 222, 84–94.
   PubMed Web of Science ®Google Scholar
• Cossarizza, A. & Salvioli, S. (2001a). Flow cytometric analysis of mitochondrial membrane potential using JC-1. Current Protocols in Cytometry. Chapter 9, Unit 9.14.
   PubMedGoogle Scholar
• Cossarizza, A., & Salvioli, S. (2001b). Analysis of mitochondria during cell death. Methods Cell Biol., 63, 467–486.
   PubMed Web of Science ®Google Scholar
• Curti, D., Malaspina, A., Facchetti, G., Camana, C., Mazzini, L., Tosca, P., (1996). Amyotrophic lateral sclerosis: Oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology, 47, 1060–1064.
   PubMed Web of Science ®Google Scholar
• Dupuis, L., Gonzalez de Aguilar, J. L., Oudart, H., de Tapia, M., Barbeito, L., & Loeffler, J. P. (2004). Mitochondria in amyotrophic lateral sclerosis: A trigger and a target. Neurodegenerative Diseases, 1(6), 245–254.
   PubMedGoogle Scholar
• Ferrarese, C., Sala, G., Riva, R., Begni, B., Zoia, C., Tremolizzo, L., et al.; Italian ALS Study Group. (2001). Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology, 56(2), 270–272.
   PubMed Web of Science ®Google Scholar
• Ferrick, D. A., Neilson, A., & Beeson, C. (2008). Advances in measuring cellular bioenergetics using extracellular flux. Drug Discovery Today, 13(5–6), 268–274.
   PubMed Web of Science ®Google Scholar
• Fiskum, G. (2000). Mitochondrial participation in ischemic and traumatic neural cell death. Journal of Neurotrauma, 17(10), 843–855.
   PubMed Web of Science ®Google Scholar
• Friedlander, R. M. (2003). Apoptosis and caspases in neurodegenerative diseases. The New England Journal of Medicine, 348(14), 1365–1375.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz, C., Colell, A., Paris, R., & Fernandez-Checa, J. C. (2000). Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB Journal, 14(7), 847–858.
   PubMedGoogle Scholar
• Hengartner, M.O. (2000). The biochemistry of apoptosis. Nature, 407, 770–776.
   PubMed Web of Science ®Google Scholar
• Jayaraman, S. (2005). Flow cytometric determination of mitochondrial membrane potential changes during apoptosis of T lymphocytic and pancreatic beta cell lines: Comparison of etramethylrhodamineethylester (TMRE), chloromethyl-X-rosamine (H2-CMX-Ros) and MitoTracker Red 580 (MTR580). Journal of Immunological Methods, 306(1–2), 68–79.
   PubMedGoogle Scholar
• Kahn, E., Lizard, G., Monier, S., Bessède, G., Frouin, F., Gambert, P., (2002). Flow cytometry and factor analysis evaluation of confocal image sequences of morphologic and functional changes occurring at the mitochondrial level during 7-ketocholesterol-induced cell death. Analytical and Quantitative Cytology and Histology, 24(6), 355–362.
   PubMedGoogle Scholar
• Khan, S. M., Cassarino, D. S., Abramova, N. N., Keeney, P. M., Borland, M. K., Trimmer, P. A., (2000). Alzheimer's disease cybrids replicate betaamyloid abnormalities through cell death pathways. Annals of Neurology, 48, 148–155.
   PubMed Web of Science ®Google Scholar
• Kiktenko, A. I., Zlobina, G. P., Brusov, O. S., & Zakharova, M. N. (2005). Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis. Zh Nevrol Psikhiatr Im S S Korsakova, 105(3), 40–42.
   PubMedGoogle Scholar
• Kile, B. T. (2009). The role of the intrinsic apoptotic pathway in platelet life and death. Journal of Thrombosis and Haemostasis, 7(1), 214–217.
   PubMedGoogle Scholar
• Koopman, C., Reutelingsperger, C. P. M., Kuijten, G. A. M., Keehnen, R. M. J., Pals, S. T., & van Oers, M. H. J. (1994). Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 84, 1415–1420.
   PubMed Web of Science ®Google Scholar
• Kushnareva, Y. E., Polster, B. M., Sokolove, P. M., Kinnally, K. W., & Fiskum, G. (2001). Mitochondrial precursor signal peptide induces a unique permeability transition and release of cytochrome c from liver and brain mitochondria. Archives of Biochemistry and Biophysics, 386(2), 251–260.
   PubMedGoogle Scholar
• Leytin, V., Allen, D. J., Mutlu, A., Gyulkhandanyan, A. V., Mykhaylov, S., & Freedman, J. (2009). Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Laboratory Investigations, 89(4), 374–384.
   PubMedGoogle Scholar
• Leytin, V., Allen, D. J., Mutlu, A., Mykhaylov, S., Lyubimov, E., & Freedman, J. (2008). Platelet activation and apoptosis are different phenomena: evidence from the sequential dynamics and the magnitude of responses during platelet storage. British Journal of Haematology, 142(3), 494–497.
   PubMed Web of Science ®Google Scholar
• Leytin, V., Mody, M., Semple, J. W., Garvey, B., & Freedman, J. (2000). Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations. Biochemical and Biophysical Research Communications, 269(1), 85–90.
   PubMedGoogle Scholar
• Menzies, F. M., Ince, P. G., & Shaw, P. J. (2002). Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochemistry International, 40(6), 543–551.
   PubMedGoogle Scholar
• Merlo Pich, M., Bovina, C., Formiggini, G., Cometti, G. G., Ghelli, A., Parenti, C. G., (1996). Inhibitor sensitivity of respiratory complex I in human platelets, a possible biomarker of ageing. FEBS Letters, 380, 176–178.
   PubMed Web of Science ®Google Scholar
• Nakano, Y., Hirayama, K., & Terao, K. (1987). Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Archives of Neurology, 44(1), 103–106.
   PubMedGoogle Scholar
• Perrotta, P. L., Perrotta, C. L., & Snyder, E. L. (2003). Apoptotic activity in stored human platelets. Transfusion, 43(4), 526–535.
   PubMed Web of Science ®Google Scholar
• Picker, S. M., Schneider, V., Oustianskaia, L., & Gathof, B. S. (2009). Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion, 49(11), 2311–2318.
   PubMed Web of Science ®Google Scholar
• Pignatelli, P., Pulcinelli, F. M., Lenti, L., Gazzaniga, P. P., & Violi, F. (1998). Hydrogen peroxide is involved in collagen-induced platelet activation. Blood, 91(2), 484–490.
   PubMed Web of Science ®Google Scholar
• Polster, B. M., Kinnally, K. W., & Fiskum, G. (2001). BH3 death domain peptide induces cell type-selective mitochondrial outer membrane permeability. Journal of Biological Chemistry, 276(41), 37887–37894.
   PubMedGoogle Scholar
• Rosado, J. A., Redondo, P. C., Salido, G. M., Gómez-Arteta, E., Sage, S. O., & Pariente, J. A. (2004). Hydrogen peroxide generation induces pp60src activation in human platelets: Evidence for the involvement of this pathway in store-mediated calcium entry. Journal of Biological Chemistry, 279(3), 1665–1675.
   PubMed Web of Science ®Google Scholar
• Salvioli S., Ardizzoni, A., Franceschi C., & Cossarizza A. (1997). JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess DY in intact cells. Implications for studies on mitochondrial functionality during apoptosis. FEBS Letters, 411, 77–82.
   PubMed Web of Science ®Google Scholar
• Seghatchian, J., & Krailadsiri, P. (2001). Platelet storage lesion and apoptosis: are they related? Transfusion and Apheresis Science, 24(1), 103–105.
   PubMedGoogle Scholar
• Seno, T., Inoue, N., Gao, D., Okuda, M., Sumi, Y., Matsui, K., (2001). Involvement of NADH/NADPH oxidase in human platelet ROS production. Thrombosis Research, 103(5), 399–409.
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H. (2007). Mitochondria in Cybrids Containing mtDNA from persons with mitochondriopathies. Journal of Neuroscience Research, 85, 3416–3428.
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H., Parks, J. K., Cassarino, D. S., Trimmer, P. A., Miller, S. W., Maguire, D. J., (1998). Mitochondria in sporadic amyotrophic lateral sclerosis. Experimental Neurology, 153, 135–142.
   PubMed Web of Science ®Google Scholar
• Swerdlow, R. H., Parks, J. K., Pattee, G., & Parker, W. D. Jr. (2000). Role of mitochondria in amyotrophic lateral sclerosis. Amyotroph Lateral Sclerosis and Other Motor Neuron Disorders, 1, 185–190.
   PubMed Web of Science ®Google Scholar
• Trimmer, P. A., Keeney, P. M., Borland, M. K., Simon, F. A., Almeida, J., Swerdlow, R. H., (2004). Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiology of Disease, 15, 29–39.
   PubMed Web of Science ®Google Scholar
• Trimmer, P. A., Swerdlow, R. H., Parks, J. K., Keeney, P., Bennett, J. P. Jr., Miller, S. W., (2000). Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Experimental Neurology, 162, 37–50.
   PubMed Web of Science ®Google Scholar
• Verhoeven, A. J., Verhaar, R., Gouwerok, E. G., & de Korte, D. (2005). The mitochondrial membrane potential in human platelets: A sensitive parameter for platelet quality. Transfusion, 45(1), 82–89.
   PubMedGoogle Scholar
• Vielhaber, S., Kunz, D., Winkler, K., Weidemann, F. R., Kirches, E., Feistner, H., (2000). Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain, 123, 1339–1348.
   PubMed Web of Science ®Google Scholar
• Wiedemann, F. R., Winkler, K., Kuznetsov, A. V., Bartels, C., Vielhaber, S., Feistner, H., (1998). Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. Journal of Neurological Science, 156, 65–72.
   PubMed Web of Science ®Google Scholar
• Xu, J., Shi, C., Li, Q., Wu, J., Forster, E. L., & Yew, D. T. (2007). Mitochondrial dysfunction in platelets and hippocampi of senescence-accelerated mice. Journal of Bioenergetics and Biomembranes, 39(2), 195–202.
   PubMedGoogle Scholar
• Yuan, J., & Yankner, B. A. (2000). Apoptosis in the nervous system. Nature, 407, 802–809.
   PubMed Web of Science ®Google Scholar